Biocon has target of Rs 390: DD Sharma

Biocon has target of Rs 390, says DD Sharma, Senior Vice President Research, Anand Rathi.

Sharma told CNBC-TV18, "We are expecting good results from Biocon from the Q1 this week and my target for the stock is Rs 390."

The company's trailing 12-month (TTM) EPS was at Rs 22.96 per share. (Mar, 2011). The stock's price-to-earnings (P/E) ratio was 16.15. The latest book value of the company is Rs 97.29 per share. At current value, the price-to-book value of the company was 3.81. The dividend yield of the company was 1.21%.